Abstract
Background
Mucolipidosis II α/β (ML II) is an autosomal recessive disease associated with the abnormality of lysosomal enzyme trafficking.
Case presentation
We present an unusual patient with: (a) marked skeletal anomalies with secondary hyperparathyroidism; (b) serum intact parathyroid hormone level normalized by 7 weeks but abnormally elevated serum alkaline phosphate persisted; and (c) two mutations identified in the GNPTAB gene. One mutation, c.3503_3504delTC, is the most common mutation in ML II. However, the second mutation, c.2896delA, is a rare mutation for which clinical presentation has not been described previously.
Acknowledgments
None.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: There were no competing interests.
References
1. Velho RV, Harms FL, Danyukova T, Ludwig NF, Friez MJ, et al. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta and type III gamma: update on GNPTAB and GNPTG mutations. Hum Mutat 2019;40:842–64.10.1002/humu.23748Search in Google Scholar PubMed
2. Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, et al. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 2004;12:87–92.10.1038/sj.ejhg.5201044Search in Google Scholar PubMed
3. Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999;105:151–6.10.1007/s004399900075Search in Google Scholar PubMed
4. Bao M, Booth JL, Elmendorf BJ, Canfield WM. Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. I. Purification and subunit structure. J Biol Chem 1996;271:31437–45.10.1074/jbc.271.49.31437Search in Google Scholar PubMed
5. Raas-Rothschild A, Cormier-Daire V, Bao M, Genin E, Salomon R, et al. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC). J Clin Invest 2000;105:673–81.10.1172/JCI5826Search in Google Scholar PubMed PubMed Central
6. Kudo M, Bao M, D’Souza A, Ying F, Pan H, et al. The alpha- and beta-subunits of the human UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase [corrected] are encoded by a single cDNA. J Biol Chem 2005;280:36141–9.10.1074/jbc.M509008200Search in Google Scholar PubMed
7. National Center for Biotechnology Information. NM_024312.4 (GNPTAB):c.2896delA (p.Met966Cysfs). Updated Nov 25, 2018. Available from: https://www.ncbi.nlm.nih.gov/clinvar/variation/96120/#clinical-assertions.Search in Google Scholar
8. Unger S, Paul DA, Nino MC, McKay CP, Miller S, et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. Eur J Pediatr 2005;164:236–43.10.1007/s00431-004-1591-xSearch in Google Scholar PubMed
9. Heo JS, Choi KY, Sohn SH, Kim C, Kim YJ, et al. A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth. Korean J Pediatr 2012;55:438–44.10.3345/kjp.2012.55.11.438Search in Google Scholar PubMed PubMed Central
©2019 Walter de Gruyter GmbH, Berlin/Boston
